Research scientist
Centre for aging research
Regenstrief Institute
United States of America
Dr. Campbell has completed his Doc of Pharmacy, from Butler University in 2002.As an aging brain pharmacoepidemiologist he is most interested in the impact medications may have on the development or progression of cognitive dysfunction. This work extends to both the acute care (Pharmacologic Management of Delirium, PMD study) and ambulatory environments (COMET-AD, comparative effectiveness study in Alzheimer’s Disease).
Dr. Campbell’s interest is in medication management of older adults with cognitive impairment.